Lahey Hospital & Medical Center Agrees To Become One Of The U.S. Sites For The LIBERTY Robotic System's First Human Trial
Portfolio Pulse from Happy Mohamed
Microbot Medical Inc. (NASDAQ:MBOT) announced that Lahey Hospital & Medical Center will be one of the U.S. sites for the first human trial of the LIBERTY Robotic Surgical System, a single-use endovascular robotic system. This marks a significant step towards regulatory approval and commercialization.
May 25, 2023 | 12:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Microbot Medical's LIBERTY Robotic Surgical System will undergo its first human trial at Lahey Hospital, bringing the company closer to regulatory approval and commercialization.
The announcement of the first human trial for Microbot Medical's LIBERTY Robotic Surgical System at Lahey Hospital is a significant milestone for the company. This development brings the company closer to regulatory approval and commercialization, which could positively impact its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100